Skip to main content
Instil Bio, Inc. logo

Instil Bio, Inc. — Investor Relations & Filings

Ticker · TIL ISIN · US45783C2008 LEI · 529900HW1XOEQEVG5T88 US Manufacturing
Filings indexed 239 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country US United States of America
Listing US TIL

About Instil Bio, Inc.

https://instilbio.com/

Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops novel cell therapies for the treatment of cancer. The company's work has centered on developing a pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies designed to target solid tumors. Its lead asset is AXN-2510, a therapeutic candidate for solid tumor cancers.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report
2026-05-15 English
8-K
Regulatory Filings
2026-05-15 English
ARS - Instil Bio, Inc. (0001789769) (Filer)
Annual Report
2026-04-24 English
8-K - Instil Bio, Inc. (0001789769) (Filer)
Regulatory Filings
2026-04-03 English
S-8 - Instil Bio, Inc. (0001789769) (Filer)
Registration Form
2026-03-27 English
10-K - Instil Bio, Inc. (0001789769) (Filer)
Annual Report FY 2025
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.